ANDREW I KOVEN
CIK 1258673 · President & Chief Business Off · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$44.6K
Companies
7
Total Filings
48
Lifetime Open-Market Net
-$4.68M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| MetaVia Inc. (NRBO) Delisted | Director | 21,339 | $2.36 | $50.4K | $0 | 6 | 2026-06-08 |
| KALA | Director | 16,972 | $2.63 | $44.6K | $0 | 10 | 2025-06-17 |
| Aralez Pharmaceuticals Inc. (ARLZ) Delisted | President & Chief Business Off | 1,183,419 | — | — | -$8.0K | 11 | 2018-06-06 |
| POZEN INC /NC (POZN) Delisted | President, Chief Business Ofc. | 1,476,674 | — | — | $0 | 1 | 2015-06-04 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | EVP, CAO, GC and Secretary | 0 | — | — | -$4.67M | 10 | 2015-01-30 |
| INSPIRE PHARMACEUTICALS INC (ISPH) Delisted | EVP & Chief Admin & Legal Ofc | 0 | — | — | $0 | 4 | 2011-05-16 |
| SEPRACOR INC /DE/ (SEPR) Delisted | Exec VP, General Counsel | 81,668 | — | — | $0 | 4 | 2009-10-19 |
Recent Filings · Page 2 of 5
48 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-09-03 | MetaVia Inc. (NRBO) Delisted | Grant (A) | — | $0 | EDGAR |
| 2021-06-21 | KALA | Grant (A) | +25,000 | $0 | EDGAR |
| 2020-06-29 | KALA | Grant (A) | +28,000 | $0 | EDGAR |
| 2019-06-07 | KALA | Grant (A) | — | $0 | EDGAR |
| 2018-06-14 | KALA | Grant (A) | — | $0 | EDGAR |
| 2018-06-06 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Sell (S) | −156,573 | -$58.6K | EDGAR |
| 2018-05-16 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Sell (S) | −13,964 | -$7.3K | EDGAR |
| 2018-03-21 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Sell (S) | −9,739 | -$16.6K | EDGAR |
| 2017-10-02 | KALA | Grant (A) | — | $0 | EDGAR |
| 2017-06-06 | Aralez Pharmaceuticals Inc. (ARLZ) Delisted | Sell (S) | −161,906 | -$207.1K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.